Literature DB >> 14616158

A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population.

B C-Y Wong1, W M Wong, K L Cheung, T S M Tong, P Rozen, G P Young, K W Chu, J Ho, W L Law, H M Tung, K C Lai, W H C Hu, C K Chan, S K Lam.   

Abstract

BACKGROUND: Colorectal cancer screening by guaiac faecal occult blood test has been shown to reduce the incidence and mortality of colorectal cancer in Western populations. The optimal faecal occult blood test, whether guaiac or immunochemical, for colorectal cancer screening in the Chinese population remains to be defined. AIM: To compare the performance characteristics of a sensitive guaiac-based faecal occult blood test (Hemoccult SENSA) and an immunochemical faecal occult blood test (FlexSure OBT) in a Chinese population referred for colonoscopy.
METHODS: One hundred and thirty-five consecutive patients who were referred for colonoscopy and who met the study inclusion criteria took samples for the two faecal occult blood tests simultaneously from three successive stool specimens, with no dietary restrictions. All tests were developed and interpreted by a single experienced technician who was blind to the clinical diagnosis. The sensitivity, specificity and positive predictive value for the detection of colorectal adenomas and cancers were estimated for the two tests.
RESULTS: The sensitivity, specificity and positive predictive value for the detection of significant colorectal neoplasia (adenomas > or = 1.0 cm and cancers) were 91%, 70% and 18% for Hemoccult SENSA and 82%, 94% and 47% for FlexSure OBT. The specificity and positive predictive value were significantly higher for FlexSure OBT than for Hemoccult SENSA (P < 0.001 and P = 0.016, respectively). Combining the positive results from both faecal occult blood tests did not improve the accuracy.
CONCLUSION: The positive predictive value of the immunochemical faecal occult blood test for the detection of significant colorectal neoplasia was 29% better than that of the sensitive guaiac-based test. This may relate to the Chinese diet and requires further study. The poor specificity of the sensitive guaiac-based test, without dietary restriction, makes it less useful for colorectal cancer screening in a Chinese population.

Entities:  

Mesh:

Year:  2003        PMID: 14616158     DOI: 10.1046/j.1365-2036.2003.01783.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  15 in total

Review 1.  Effect of verification bias on the sensitivity of fecal occult blood testing: a meta-analysis.

Authors:  Alan S Rosman; Mark A Korsten
Journal:  J Gen Intern Med       Date:  2010-05-25       Impact factor: 5.128

2.  Evaluating an Electronic Measure of Colorectal Cancer Screening at Indian Health Service Facilities, 2008-2010.

Authors:  Diana Redwood; Anil Suryaprasad; Donald Haverkamp; Charlene Wong; Ellen Provost; David Espey
Journal:  IHS Prim Care Provid       Date:  2014-06

3.  Performance of the immunochemical fecal occult blood test in predicting lesions in the lower gastrointestinal tract.

Authors:  Tsung-Hsien Chiang; Yi-Chia Lee; Chia-Hung Tu; Han-Mo Chiu; Ming-Shiang Wu
Journal:  CMAJ       Date:  2011-08-02       Impact factor: 8.262

Review 4.  Colorectal cancer screening.

Authors:  R Scott Nelson; Alan G Thorson
Journal:  Curr Oncol Rep       Date:  2009-11       Impact factor: 5.075

5.  Prediction of flare-ups of ulcerative colitis using quantitative immunochemical fecal occult blood test.

Authors:  Motoaki Kuriyama; Jun Kato; Koji Takemoto; Sakiko Hiraoka; Hiroyuki Okada; Kazuhide Yamamoto
Journal:  World J Gastroenterol       Date:  2010-03-07       Impact factor: 5.742

6.  Cost-effectiveness of colorectal cancer screening - an overview.

Authors:  Iris Lansdorp-Vogelaar; Amy B Knudsen; Hermann Brenner
Journal:  Best Pract Res Clin Gastroenterol       Date:  2010-08       Impact factor: 3.043

7.  Perspectives of colorectal cancer screening in Germany 2009.

Authors:  Andreas Sieg; Kilian Friedrich
Journal:  World J Gastrointest Endosc       Date:  2009-10-15

8.  Is a fecal occult blood test a useful tool for judging whether to perform capsule endoscopy in low-dose aspirin users with negative colonoscopy and esophagogastroduodenoscopy?

Authors:  Hiroki Endo; Takayuki Kato; Eiji Sakai; Leo Taniguchi; Jun Arimoto; Harunobu Kawamura; Takuma Higurashi; Hidenori Ohkubo; Takashi Nonaka; Masataka Taguri; Masahiko Inamori; Takeharu Yamanaka; Takashi Sakaguchi; Yasuo Hata; Hajime Nagase; Atsushi Nakajima
Journal:  J Gastroenterol       Date:  2016-04-19       Impact factor: 7.527

9.  As tests evolve and costs of cancer care rise: reappraising stool-based screening for colorectal neoplasia.

Authors:  M Parekh; A M Fendrick; U Ladabaum
Journal:  Aliment Pharmacol Ther       Date:  2008-01-29       Impact factor: 8.171

10.  Colorectal cancer screening in an equal access healthcare system.

Authors:  Mia Debarros; Scott R Steele
Journal:  J Cancer       Date:  2013-03-20       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.